Prion-like polymerization as a signaling mechanism

Trends in Immunology

Volumn 35, Issue 12, 2014, Pages 622-630

  Cai, Xin ^a   Chen, Zhijian J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Pattern recognition receptors; Prion like polymerization; Signal transduction; Signaling

Indexed keywords

ADAPTOR PROTEIN; CRYOPYRIN; INFLAMMASOME; PATTERN RECOGNITION RECEPTOR; POLYUBIQUITIN; PRION PROTEIN; RETINOIC ACID INDUCIBLE PROTEIN I;

AMINO TERMINAL SEQUENCE; CYTOKINE PRODUCTION; IMMUNOLOGICAL MEMORY; INNATE IMMUNITY; NONHUMAN; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN POLYMERIZATION; RECEPTOR UPREGULATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84915752004     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2014.10.003     Document Type: Review

References (60)

1. Prusiner S.B. Novel proteinaceous infectious particles cause scrapie. Science 1982, 216:136-144.
2. Prusiner S.B. Prions. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:13363-13383.
3. Tuite M.F., Serio T.R. The prion hypothesis: from biological anomaly to basic regulatory mechanism. Nat. Rev. Mol. Cell Biol. 2010, 11:823-833.
4. Wickner R.B. [URE3] as an altered URE2 protein: evidence for a prion analog in Saccharomyces cerevisiae. Science 1994, 264:566-569.
5. Alberti S., et al. A systematic survey identifies prions and illuminates sequence features of prionogenic proteins. Cell 2009, 137:146-158.
6. Suzuki G., et al. A yeast prion, Mod5, promotes acquired drug resistance and cell survival under environmental stress. Science 2012, 336:355-359.
7. Saupe S.J. The [Het-s] prion of Podospora anserina and its role in heterokaryon incompatibility. Semin. Cell Dev. Biol. 2011, 22:460-468.
8. Si K., et al. Aplysia CPEB can form prion-like multimers in sensory neurons that contribute to long-term facilitation. Cell 2010, 140:421-435.
9. Majumdar A., et al. Critical role of amyloid-like oligomers of Drosophila Orb2 in the persistence of memory. Cell 2012, 148:515-529.
10. Kim H.J., et al. Mutations in prion-like domains in hnRNPA2B1 and hnRNPA1 cause multisystem proteinopathy and ALS. Nature 2013, 495:467-473.
11. Ramaswami M., et al. Altered ribostasis: RNA-protein granules in degenerative disorders. Cell 2013, 154:727-736.
12. Jucker M., Walker L.C. Self-propagation of pathogenic protein aggregates in neurodegenerative diseases. Nature 2013, 501:45-51.
13. Yoneyama M., Fujita T. RNA recognition and signal transduction by RIG-I-like receptors. Immunol. Rev. 2009, 227:54-65.
14. Hornung V., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 2006, 314:994-997.
15. Pichlmair A., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 2006, 314:997-1001.
16. Goubau D., et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature 2014, 514:372-375.
17. Zeng W., et al. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 2010, 141:315-330.
18. Jiang X., et al. Ubiquitin-induced oligomerization of the RNA sensors RIG-I and MDA5 activates antiviral innate immune response. Immunity 2012, 36:959-973.
19. Seth R.B., et al. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-κB and IRF3. Cell 2005, 122:669-682.
20. Liu S., et al. MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades. Elife 2013, 2:e00785.
21. Ferrao R., Wu H. Helical assembly in the death domain (DD) superfamily. Curr. Opin. Struct. Biol. 2012, 22:241-247.
22. Park H.H., et al. Death domain assembly mechanism revealed by crystal structure of the oligomeric PIDDosome core complex. Cell 2007, 128:533-546.
23. Qiao Q., et al. Structural architecture of the CARMA1/Bcl10/MALT1 signalosome: nucleation-induced filamentous assembly. Mol. Cell 2013, 51:766-779.
24. Sun L., et al. The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol. Cell 2004, 14:289-301.
25. Meylan E., et al. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 2005, 437:1167-1172.
26. Kawai T., et al. IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat. Immunol. 2005, 6:981-988.
27. Xu L.G., et al. VISA is an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 2005, 19:727-740.
28. Hou F., et al. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 2011, 146:448-461.
29. Xu H., et al. Structural basis for the prion-like MAVS filaments in antiviral innate immunity. Elife 2014, 3:e01489.
30. Alberti S., et al. Biochemical, cell biological, and genetic assays to analyze amyloid and prion aggregation in yeast. Methods Enzymol. 2010, 470:709-734.
31. Cai X., et al. Prion-like polymerization underlies signal transduction in antiviral immune defense and inflammasome activation. Cell 2014, 156:1207-1222.
32. Cui S., et al. The C-terminal regulatory domain is the RNA 5'-triphosphate sensor of RIG-I. Mol. Cell 2008, 29:169-179.
33. Jiang F., et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 2011, 479:423-427.
34. Luo D., et al. Structural insights into RNA recognition by RIG-I. Cell 2011, 147:409-422.
35. Kowalinski E., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 2011, 147:423-435.
36. Peisley A., et al. RIG-I forms signaling-competent filaments in an ATP-dependent, ubiquitin-independent manner. Mol. Cell 2013, 51:573-583.
37. Peisley A., et al. Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I. Nature 2014, 509:110-114.
38. Berke I.C., Modis Y. MDA5 cooperatively forms dimers and ATP-sensitive filaments upon binding double-stranded RNA. EMBO J. 2012, 31:1714-1726.
39. Peisley A., et al. Cooperative assembly and dynamic disassembly of MDA5 filaments for viral dsRNA recognition. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:21010-21015.
40. Wu B., et al. Structural basis for dsRNA recognition, filament formation, and antiviral signal activation by MDA5. Cell 2013, 152:276-289.
41. Kuniyoshi K., et al. Pivotal role of RNA-binding E3 ubiquitin ligase MEX3C in RIG-I-mediated antiviral innate immunity. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:5646-5651.
42. Gack M.U., et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 2007, 446:916-920.
43. Oshiumi H., et al. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 2010, 8:496-509.
44. Potter J.A., et al. Crystal structure of human IPS-1/MAVS/VISA/Cardif caspase activation recruitment domain. BMC Struct. Biol. 2008, 8:11.
45. Wu B., et al. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol. Cell 2014, 55:511-523.
46. Toyama B.H., et al. The structural basis of yeast prion strain variants. Nature 2007, 449:233-237.
47. Frederick K.K., et al. Distinct prion strains are defined by amyloid core structure and chaperone binding site dynamics. Chem. Biol. 2014, 21:295-305.
48. Martinon F., et al. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 2002, 10:417-426.
49. Lamkanfi M., Dixit V.M. Mechanisms and functions of inflammasomes. Cell 2014, 157:1013-1022.
50. Lu A., et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 2014, 156:1193-1206.
51. Broz P., et al. Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J. Exp. Med. 2010, 207:1745-1755.
52. Daskalov A., et al. Genomic clustering and homology between HET-S and the NWD2 STAND protein in various fungal genomes. PLoS ONE 2012, 7:e34854.
53. Dinarello C.A. Interleukin-1β and the autoinflammatory diseases. N. Engl. J. Med. 2009, 360:2467-2470.
54. Baroja-Mazo A., et al. The NLRP3 inflammasome is released as a particulate danger signal that amplifies the inflammatory response. Nat. Immunol. 2014, 15:738-748.
55. Franklin B.S., et al. The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation. Nat. Immunol. 2014, 15:727-737.
56. Seuring C., et al. The mechanism of toxicity in HET-S/HET-s prion incompatibility. PLoS Biol. 2012, 10:e1001451.
57. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
58. Collins S.R., et al. Mechanism of prion propagation: amyloid growth occurs by monomer addition. PLoS Biol. 2004, 2:e321.
59. Knowles T.P., et al. An analytical solution to the kinetics of breakable filament assembly. Science 2009, 326:1533-1537.
60. Chernoff Y.O., et al. Role of the chaperone protein Hsp104 in propagation of the yeast prion-like factor [psi+]. Science 1995, 268:880-884.